Overview

The Effect of an Oral Supplement,TK3 (Tryptophan and Thiamine) on the Quality of Life and Chemotherapy Tolerance in Cancer Patients With Advanced Disease.

Status:
Unknown status

Trial end date:
2019-05-01

Target enrollment:

Participant gender:

Summary

The product under investigation relates to a pharmaceutical composition containing a pyrimidine nitrogen base, thymine, and the essential amino acid tryptophan. This product seems to have effect on quality of life and enhance adverse affects of chemotherapy in cancer patients.

Phase:

Phase 2

Details

Lead Sponsor:

Faculdade de Medicina do ABC

Treatments:

Thiamine
Tryptophan